Tag: withdrawal

A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.

An international group of researchers, including several with financial ties to manufacturers of antidepressants, explore possible explanations for why long-term users of antidepressants become chronically depressed.

Psychiatrist and psychologist outline pharmacological and psychotherapeutic strategies for discontinuing antidepressants.

Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.

New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.

Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.

Findings point to the role of withdrawal symptoms and prescriber practices in long-term antidepressant use.

Effects of discontinuing SSRIs and SNRIs reported on an online forum indicate significant and long-lasting withdrawal symptoms.

A new study by Peter Groot and Jim van Os has found that tapering strips help people successfully discontinue antidepressant medications.

New understandings of medication and withdrawal experiences warrant rethinking conceptualizations of health and “madness."

A new study explores how people manage to discontinue antipsychotic medication and examines how social supports may improve outcomes.

Long-term benzodiazepine use shown to effect cognitive function during current use and for years after drug discontinuation.

Researchers find that support and self-care were helpful for users during discontinuation, but that mental health professionals were not very helpful.

Being in antidepressant withdrawal, I had come to feel very isolated and alone. What I needed was to hear real experiences of people who, like me, have struggled with the very drugs that they believed were going to help them. It was time to create a podcast.

From the Council for Evidence-Based Psychiatry: A major national newspaper is looking for people in the UK willing to share recent stories of negative effects...

Miriam Larsen-Barr's study is the largest to date on the subjective experiences of antipsychotic withdrawal, and the first to explore how people who have successfully stopped antipsychotics are able to maintain their well-being.

Many people report having one reason to go off psychiatric drugs—feeling that they just know they need to, sensing they will die if they don’t come off, etc. It is far less common to hear of someone going on psych drugs because they know they must.

I believe now that fifteen years is more than a fair try. Fifteen years of getting treatment without returning to function is actually insanity. I should have given up after year two. Instead of trusting my intuition and insight, I pushed it down and down... until it finally fought its way back to the surface.

Here I was, 15 years old and already in a long-term treatment facility. I was, on paper: crazy! This entire time, all the adults in my life had been speaking for me. I never felt like I was any of the things they said, but I went along with it. What else could I have done? Every time I rebelled, it only confirmed to my mother what she thought of me.

This week the drug monitoring and patients' rights website, RxISK, launched the Centre for Medication Withdrawal, a page dedicated to establishing what causes dependence and how to treat it.

ITV features and article and video today about the widespread problem of addiction and withdrawal from benzodiazepine drugs used to treat anxiety, including Ativan, Librium, Diazepam and Temazepam. Mother of three Sandra Minshull shares her story and discusses how Ativan “robbed her of her life.”

My prior MIA blog posts have largely addressed the problems that can occur when people try to stop taking serotonin-related antidepressants, particularly  after taking them for a long period of time. I wanted to share a few updated thoughts that I have on the problem.

In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.

It is hard to believe that a year has gone past since I posted Playing the Odds: Antidepressant Withdrawal and the Problem of Informed Consent. The feedback I received underscored the more controversial aspects of SSRI toxicity.  Common themes concerned the abrupt onset of new symptoms 3 to 12 months after stopping the drug, reinstatement of the drug failing to help withdrawal related symptoms, the possibility that withdrawal-related symptoms can persist indefinitely and concerns about using benzodiazepines to help with tardive akathisia.

For the last month or so, Mad in America has been hard at work building a directory of “mental health” providers across North America (and eventually, we hope, the world) who will work with people wanting to come off psychotropic drugs.  I’ve been honored to have been tasked with the responsibility of building this directory, and I have to say, it’s been inspiring to talk to people all over the country who do this work, and who “get it”.